An operationalization framework for lifecycle health technology assessment: a Health Technology Assessment International Global Policy Forum Task Force report
Year: 2024
Type: article
Abstract: Operationalization guidance is needed to support health technology assessment (HTA) bodies considering implementing lifecycle HTA (LC-HTA) approaches. The 2022 Health Technology Assessment International (HTAi) Global Policy Forum (GPF) established a Task Force to develop a position paper on LC-HTA. In its first paper, the Task Force established a definition and framework for LC-HTA in order to tailor it to specific decision problems. This second paper focused on the provision of practical operational guidance to implement LC-HTA. Detailed descriptions of the three LC-HTA operational steps are provided (defining the decision problem, sequencing of HTA activities, and developing optimization criteria) and accompanied by worked examples and an operationalization checklist with 20 different questions for HTA bodies to consider when developing an LC-HTA approach. The questions were designed to be applicable across different types of HTA and scenarios, and require adaptation to local jurisdictions, remits, and context.
Institutions: National Institute for Health and Care Excellence, Canada's Drug Agency, MSD (Switzerland), Amgen (United States), Amgen (Australia), Institute of Health Economics, Roche (Netherlands), Sanofi (France), Menarini Group (Luxembourg), Menarini Group (Italy), Menarini Group (Germany), Tufts Medical Center, BioMarin (United Kingdom), BioMarin (United States), Zorginstituut Nederland
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: gold
Estimated APC paid: $3,450
OpenAlex ID: W4396975786